Different Approaches for the Management of Post-dural Puncture Headache

• Status: Completed
• Trial end date: 2020-12-30
• Target enrollment: 0
• Participant gender: Female

Summary

Detecting the efficacy and safety of trans-nasal sphenopalatine ganglion block using either lidocaine 2% or bupivacaine 0.5 % as a treatment line for post-dural puncture headache

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bahaa Mohammed Refaie
• Treatments: Acetaminophen

Criteria

Inclusion Criteria:

• The ASA physical condition І-П

• the patient underwent CS under spinal anesthesia

• The headache developed within 5 days after the dural puncture

• There is no different explanation for the headache

Exclusion Criteria:

• coagulopathy

• history of nasal bleeding

• nasal polyp

• septal deviation

• local anesthetics reaction